Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of Belimumab in Early Lupus
NCT03543839Phase 4Recruiting
- Sponsor
- Northwell Health
- Start
- Sep 2020
- Primary completion
- Sep 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in systemic lupus erythematosus (SLE) comparing Belimumab, Belimumab/Placebo and Placebo (3 arms). Primary endpoint: Frequency of anergic autoreactive naïve B cells at 1 year. Started Sep 2020; status: recruiting.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03543839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03543839.